Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | KOPRAN Kopran Limited Pharma · Small | WANBURY Wanbury Limited Pharma · Small | AHCL Anlon Healthcare Limited Pharma · Small | ANUHPHR Anuh Pharma Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 26 | 64 | 55 | 50 |
| Verdict | OVERVALUED | UNDERVALUED | FAIR VALUE | FAIR VALUE |
| Style | OVERVALUED | Growth at Value | FAIR_VALUE | FAIR_VALUE |
| Piotroski | 7/9 | 7/9 | 6/9 | 6/9 |
| Valuation | 4/30 | 16/30 | 10/30 | 16/30 |
| Growth | 3/25 | 21/25 | 21/25 | 12/25 |
| Quality | 0/20 | 18/20 | 11/20 | 2/20 |
| Balance Sheet | 10/15 | 0/15 | 10/15 | 12/15 |
| Cash Flow | 4/10 | 4/10 | 0/10 | 4/10 |
| Price | ₹183.25 | ₹265.75 | ₹15.14 | ₹77.55 |
| P/E | 34.20 | 13.30 | 28.20 | 18.50 |
| P/B | 1.67 | 6.44 | 3.49 | 2.16 |
| ROE | 4.91% | 68.40% | 18.40% | 12.10% |
| ROCE | 6.65% | 30.80% | 20.80% | 15.90% |
| Debt / Equity | 0.29 | 1.54 | 0.19 | 0.00 |
| FCF Yield | 0.23% | — | — | 1.98% |
| Dividend Y | 1.63% | — | — | 1.98% |
| Altman Z | 3.32 | 3.83 | 5.12 | 4.96 |
| Promoter % | 44.43% | 43.01% | 52.68% | 71.79% |
| Mkt Cap (₹Cr) | 879.00 | 928.00 | 805.00 | 759.00 |
| Graham # | ₹114.86 | ₹132.63 | ₹7.25 | ₹56.9 |
| Fair PE | 2.9 | 42.0 | 42.0 | 42.0 |
| MoS % | -1069.4% | +66.6% | +33.2% | +55.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startKOPRAN60
WANBURY102
AHCL16
ANUHPHR35